QA: Vertex Pharmaceuticals INC MA in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000875320_2020_Vertex_Pharmaceuticals_INC_MA.pdf

Logs

Graph

Absolute values for 0000875320, Vertex Pharmaceuticals INC MA

  xvar xval
0 AssetsCurrent 4,822,829,000
1 IntangibleAssetsNetIncludingGoodwill 1,402,158,000
2 PropertyPlantAndEquipmentNet 758,085,000
3 remainder_Assets 1,335,393,000
4 LiabilitiesCurrent 1,334,827,000
5 LiabilitiesNoncurrent 183,318,000
6 remainder_Liabilities 715,076,000
7 CostOfGoodsAndServicesSold 617,862,805
8 SellingGeneralAndAdministrativeExpense 792,737,685
9 ResearchAndDevelopmentExpense 1,854,952,387
10 remainder_Expenses -1,230,748,365
11 remainder_Revenues 5,522,297,204
12 remainder_NetIncome 741,035,071
13 remainder_ComprehensiveNetIncome 17,349,157
  yvar yval
0 Assets 8,318,465,000
1 Liabilities 2,233,221,000
2 Expenses 2,034,804,512
3 Revenues 5,522,297,204
4 StockholdersEquity 6,085,244,000
5 NetIncome 4,228,527,763
6 ComprehensiveNetIncome 4,237,202,342
7 BaseVar 9,433,585,972
8 EconomicCapitalRatiobeforeLimitedLiability 3.32
9 EconomicCapitalRatio 3.90

Edgar->Model Mapping

Feature Distribution

Change over Time